Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.600
-0.200 (-5.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LIXT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 42 | 34 | 5 | 5 | 8 | 16 | |
| Market Cap Growth | 1301.90% | 649.97% | -13.63% | -37.62% | -48.20% | -58.30% | |
| Enterprise Value | 38 | 34 | 6 | 4 | 5 | 14 | |
| Last Close Price | 3.60 | 3.93 | 2.03 | 2.35 | 5.09 | 11.90 | |
| PB Ratio | 3.99 | 3.12 | 5.52 | 1.32 | 1.64 | 3.42 | |
| P/TBV Ratio | 5.27 | 4.32 | - | 10.68 | 5.09 | 12.68 | |
| Debt / Equity Ratio | 0.09 | 0.09 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.37 | -0.37 | -1.26 | -1.05 | -1.04 | -1.01 | |
| Net Debt / FCF Ratio | 1.29 | 1.29 | 0.33 | 0.98 | 1.16 | 1.16 | |
| Quick Ratio | 3.83 | 3.83 | 3.26 | 13.39 | 13.53 | 15.92 | |
| Current Ratio | 3.88 | 3.88 | 3.60 | 13.73 | 14.05 | 16.81 | |
| Return on Equity (ROE) | -101.95% | -101.95% | -148.73% | -111.07% | -126.81% | -137.28% | |
| Return on Assets (ROA) | -46.00% | -46.00% | -81.88% | -64.47% | -74.05% | -81.39% | |
| Return on Capital Employed (ROCE) | -44.80% | -44.80% | -431.90% | -127.40% | -122.20% | -140.30% | |
| Earnings Yield | -14.53% | -17.55% | -78.55% | -96.24% | -74.50% | -41.13% | |
| FCF Yield | -7.57% | -9.25% | -69.32% | -81.22% | -54.43% | -25.33% | |
| Buyback Yield / Dilution | -115.21% | -115.21% | -17.41% | -21.10% | -17.41% | -19.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.